MedTrace Logo

The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels

NCT01712867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2018-04-11

No results posted yet for this study

Summary

The primary objective is to determine the efficacy of phytosterol esters of omega-3 (Vayarol) versus Omega-3 acids ethyl esters in reducing triglyceride levels in hypertriglyceridemia patients with fasting triglyceride levels ≥ 200 and \< 500 mg/dL.

Conditions

  • Patients With Hypertriglyceridemia

Interventions

OTHER

Omega-3 acid ethyl esters

4 capsules/day for 12 weeks

OTHER

Phytosterol esters of omega-3

4 capsules/day for 12 weeks

Sponsors & Collaborators

  • Daewon Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Enzymotec

    lead INDUSTRY

Principal Investigators

  • Yossi Azuri, MD · Maccabi Healthcare Services, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01712867 on ClinicalTrials.gov